20 (AIDX) Revenue (2025 - 2026)
20's (AIDX) quarterly Revenue came in at $353375.0 in Q1 2026, down 36.19% YoY from $553820.0 in Q1 2025, and down 36.19% on a QoQ basis from $553820.0 in Q1 2025.
20 (AIDX) Revenue (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Revenue data on file, last reported at $353375.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.90 Bn | 194.30 Bn | 7.27 Bn | 12.59 Bn |
| 2 | Stryker | 130.01 Bn | 126.54 Bn | 4.50 Bn | 6.59 Bn |
| 3 | Medtronic | 120.53 Bn | 111.31 Bn | 6.41 Bn | 9.81 Bn |
| 4 | Boston Scientific | 74.77 Bn | 74.24 Bn | 3.85 Bn | 5.44 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 1.74 Bn |
| 6 | Dexcom | 34.74 Bn | 32.79 Bn | 830.00 Mn | 1.31 Bn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 5.30 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 9.61 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 1.49 Bn |
| 10 | 20 | 5.69 Mn | 1.15 Mn | 304,727.00 | 730,571.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 353,375.00 |
| Mar 31, 2025 | 553,820.00 |